CDKN1B and breast cancer: Furthermore, while a number of studies have focused on quantitative changes, such as the fact that the low levels of p27 in breast cancer cells were due to the high expression of SKP2 [14,40], very little attention has been paid to the relationship between p21 and p57 and SKP2-mediated degradation in breast cancer cells.